ISO 10993-7:2008

Name: ISO 10993-7:2008 — Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals
SKU: ISO 10993-7:2008
Price: 154800 RUB
Availability: InStock

Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals

Название (английский):

ISO 10993-7:2008

Biological evaluation of medical devices — Part 7: Ethylene oxide sterilization residuals

Статус документа:: Отменён
Формат:: Электронный (PDF)
Количество страниц:: 86
Дата публикации:: 13 октября 2008 г.
Издание:: ISO IS 10993 edition 2 version 1
ICS:: 11.100.20

Тип поставки:

Full version154 800 ₽Read online 24h1 200 ₽Read online 72h1 800 ₽

Язык документа:

ruen

Срок поставки:15 раб. дн. (перевод)

Цена:154 800 ₽

Описание (английский):

ISO 10993-7:2008 specifies allowable limits for residual ethylene oxide (EO) and ethylene chlorohydrin (ECH) in individual EO-sterilized medical devices, procedures for the measurement of EO and ECH, and methods for determining compliance so that devices may be released. Additional background, including guidance and a flowchart showing how the standard is applied are also included in informative annexes. EO-sterilized devices that have no patient contact (e.g., in vitro diagnostic devices) are not covered by ISO 10993-7:2008.

Abstract

Похожие стандарты

Стандарты, упомянутые в описании

Overview

ISO 10993-7:2008 - "Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals" defines how to assess and control residual ethylene oxide (EO) and ethylene chlorohydrin (ECH) in EO‑sterilized medical devices. The standard specifies allowable limits, measurement procedures, and product‑release methods so that EO‑sterilized devices with patient contact can be released safely. Devices with no patient contact (e.g., many in vitro diagnostic devices) are excluded. Ethylene glycol (EG) is discussed but no device limits are specified.

Key topics and technical requirements

Allowable limits: Devices are categorized by duration of contact (limited A, prolonged B, permanent C). Example limits:

Permanent contact (C): EO average daily dose ≤ 0.1 mg/day; maximum EO 4 mg (first 24 h), 60 mg (first 30 d), 2.5 g (lifetime). ECH average daily ≤ 0.4 mg/day; corresponding early‑use and lifetime caps apply.
Prolonged exposure (B): EO average daily ≤ 2 mg/day; maximum EO 4 mg (24 h), 60 mg (30 d). ECH average daily ≤ 2 mg/day; ECH early caps apply.

Measurement methods: Procedures for gas chromatographic determination of EO and ECH are provided (normative and informative annexes). Extraction techniques are defined, including simulated‑use extraction and exhaustive extraction criteria.

Product release and compliance: Methods include use of residue dissipation curves, release procedures with/without dissipation data, and guidance for interpreting chromatograms and establishing compliance.

Risk basis: Limits are established to protect against systemic and local effects (e.g., irritation, mutagenicity considerations) and are intended to be used alongside the broader biological evaluation in ISO 10993‑1.

Applications and users

Who uses it: medical device manufacturers, sterilization engineers, quality assurance, regulatory affairs professionals, testing laboratories, and clinical safety assessors.

Practical uses:

Validate EO sterilization processes and specify acceptable post‑sterilization residues.
Define sampling and analytical testing protocols (GC methods, extraction).
Establish product release criteria and justify device safety in regulatory submissions.
Inform material selection and sterilization decisions during device design to minimize residual EO/ECH exposure.

Related standards

ISO 10993 series (biological evaluation) - especially ISO 10993‑1, ‑3, ‑10, ‑12, ‑17

ISO 11135‑1 (EO sterilization process requirements)

Annexes in ISO 10993‑7 include guidance on GC methods, extraction conditions, flowcharts, and rationale for limit derivation.

ISO 10993-7:2008 is essential for ensuring EO‑sterilized medical devices meet toxicological and clinical safety expectations through defined allowable limits, validated measurement methods, and clear product‑release procedures.

ISO 10993-7:2008

Abstract

Похожие стандарты

Overview

Key topics and technical requirements

Applications and users

Related standards

Технические детали

BS EN ISO 10993-14:2009

Biological evaluation of medical devices. Identification and quantification of degradation products from cera…

BS EN ISO 10993-9:2021

Biological evaluation of medical devices. Framework for identification and quantification of potential degrad…

BS EN ISO 10993-7:1996

Biological evaluation of medical devices - Ethylene oxide sterilization residuals